boehringer glp-1 advances #first #triple #agonist #bi3034701 #obesity #pipeline #glp #gip #npy2 #glucagon #glp #boehringeringelheim #obesity #glp1 #gip #npy2 #cardiometabolic #phase2 #clinicaltrials #drugdevelopment… Boehringer kickstarts two Phase III

(2025) The effect of GLP-1 agonist on idiopathic intracranial hypertension: a systematic review and meta-analysis

adipocyte-size distributions

Experimental and Therapeutic Medicine, 17 (5), 35733579

Effects of short and long term treatment of Ballota undulata on female albino rats fertility and pregnancy

The gene expression changes the peptide triggers may be more important than continuous peptide presence

Resolves quickly with proper fluid intake but requires ongoing vigilance Serious But Less Common Side Effects The MHRA highlights several serious but less common risks that patients should know about 1 : Gallbladder problems: Including gallstones Pancreatitis: Inflammation of the pancreas, which can require hospitalization Allergic reactions: Can include swelling, rash, and trouble breathing Low blood sugar: Can happen even in non-diabetic patients using GLP-1s for weight loss Hair loss: Some patients report temporary thinning of hair Warnings About Misuse Healthcare professionals are concerned about people using GLP-1 medications inappropriately just for cosmetic weight loss